The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.
Identifieur interne : 001B14 ( PubMed/Curation ); précédent : 001B13; suivant : 001B15The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.
Auteurs : Nan Zhou [République populaire de Chine] ; Yun Zhang [République populaire de Chine] ; Jin-Chun Zhang [République populaire de Chine] ; Ling Feng [République populaire de Chine] ; Jin-Ku Bao [République populaire de Chine]Source :
- Journal of the Formosan Medical Association = Taiwan yi zhi [ 0929-6646 ] ; 2014.
Descripteurs français
- KwdFr :
- Antiviraux (), Antiviraux (usage thérapeutique), Conception de médicament, Coronavirus (), Coronavirus (immunologie), Coronavirus (métabolisme), Dipeptidyl peptidase 4 (), Dipeptidyl peptidase 4 (immunologie), Dipeptidyl peptidase 4 (métabolisme), Humains, Infections à coronavirus (), Infections à coronavirus (immunologie), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (virologie), Récepteurs viraux (), Récepteurs viraux (immunologie), Récepteurs viraux (métabolisme), Vaccins antiviraux ().
- MESH :
- immunologie : Coronavirus, Dipeptidyl peptidase 4, Infections à coronavirus, Récepteurs viraux.
- métabolisme : Coronavirus, Dipeptidyl peptidase 4, Récepteurs viraux.
- traitement médicamenteux : Infections à coronavirus.
- usage thérapeutique : Antiviraux.
- virologie : Infections à coronavirus.
- Antiviraux, Conception de médicament, Coronavirus, Dipeptidyl peptidase 4, Humains, Infections à coronavirus, Récepteurs viraux, Vaccins antiviraux.
English descriptors
- KwdEn :
- Antiviral Agents (chemistry), Antiviral Agents (therapeutic use), Coronavirus (chemistry), Coronavirus (immunology), Coronavirus (metabolism), Coronavirus Infections (drug therapy), Coronavirus Infections (immunology), Coronavirus Infections (prevention & control), Coronavirus Infections (virology), Dipeptidyl Peptidase 4 (chemistry), Dipeptidyl Peptidase 4 (immunology), Dipeptidyl Peptidase 4 (metabolism), Drug Design, Humans, Receptors, Virus (chemistry), Receptors, Virus (immunology), Receptors, Virus (metabolism), Viral Vaccines (chemistry).
- MESH :
- chemical , chemistry : Antiviral Agents, Dipeptidyl Peptidase 4, Receptors, Virus, Viral Vaccines.
- chemical , immunology : Dipeptidyl Peptidase 4, Receptors, Virus.
- chemical , metabolism : Dipeptidyl Peptidase 4, Receptors, Virus.
- chemical , therapeutic use : Antiviral Agents.
- chemistry : Coronavirus.
- drug therapy : Coronavirus Infections.
- immunology : Coronavirus, Coronavirus Infections.
- metabolism : Coronavirus.
- prevention & control : Coronavirus Infections.
- virology : Coronavirus Infections.
- Drug Design, Humans.
Abstract
The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is becoming another "SARS-like" threat to the world. It has an extremely high death rate (∼50%) as there is no vaccine or efficient therapeutics. The identification of the structures of both the MERS-CoV receptor binding domain (RBD) and its complex with dipeptidyl peptidase 4 (DPP4), raises the hope of alleviating this currently severe situation. In this review, we examined the molecular basis of the RBD-receptor interaction to outline why/how could we use MERS-CoV RBD to develop vaccines and antiviral drugs.
DOI: 10.1016/j.jfma.2013.11.006
PubMed: 24342026
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001B14
Links to Exploration step
pubmed:24342026Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.</title>
<author><name sortKey="Zhou, Nan" sort="Zhou, Nan" uniqKey="Zhou N" first="Nan" last="Zhou">Nan Zhou</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhang, Yun" sort="Zhang, Yun" uniqKey="Zhang Y" first="Yun" last="Zhang">Yun Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhang, Jin Chun" sort="Zhang, Jin Chun" uniqKey="Zhang J" first="Jin-Chun" last="Zhang">Jin-Chun Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Feng, Ling" sort="Feng, Ling" uniqKey="Feng L" first="Ling" last="Feng">Ling Feng</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bao, Jin Ku" sort="Bao, Jin Ku" uniqKey="Bao J" first="Jin-Ku" last="Bao">Jin-Ku Bao</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China. Electronic address: baojinku@scu.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24342026</idno>
<idno type="pmid">24342026</idno>
<idno type="doi">10.1016/j.jfma.2013.11.006</idno>
<idno type="wicri:Area/PubMed/Corpus">001B14</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B14</idno>
<idno type="wicri:Area/PubMed/Curation">001B14</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B14</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.</title>
<author><name sortKey="Zhou, Nan" sort="Zhou, Nan" uniqKey="Zhou N" first="Nan" last="Zhou">Nan Zhou</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhang, Yun" sort="Zhang, Yun" uniqKey="Zhang Y" first="Yun" last="Zhang">Yun Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhang, Jin Chun" sort="Zhang, Jin Chun" uniqKey="Zhang J" first="Jin-Chun" last="Zhang">Jin-Chun Zhang</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Feng, Ling" sort="Feng, Ling" uniqKey="Feng L" first="Ling" last="Feng">Ling Feng</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bao, Jin Ku" sort="Bao, Jin Ku" uniqKey="Bao J" first="Jin-Ku" last="Bao">Jin-Ku Bao</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China. Electronic address: baojinku@scu.edu.cn.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of the Formosan Medical Association = Taiwan yi zhi</title>
<idno type="ISSN">0929-6646</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Coronavirus (chemistry)</term>
<term>Coronavirus (immunology)</term>
<term>Coronavirus (metabolism)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (virology)</term>
<term>Dipeptidyl Peptidase 4 (chemistry)</term>
<term>Dipeptidyl Peptidase 4 (immunology)</term>
<term>Dipeptidyl Peptidase 4 (metabolism)</term>
<term>Drug Design</term>
<term>Humans</term>
<term>Receptors, Virus (chemistry)</term>
<term>Receptors, Virus (immunology)</term>
<term>Receptors, Virus (metabolism)</term>
<term>Viral Vaccines (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux ()</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Conception de médicament</term>
<term>Coronavirus ()</term>
<term>Coronavirus (immunologie)</term>
<term>Coronavirus (métabolisme)</term>
<term>Dipeptidyl peptidase 4 ()</term>
<term>Dipeptidyl peptidase 4 (immunologie)</term>
<term>Dipeptidyl peptidase 4 (métabolisme)</term>
<term>Humains</term>
<term>Infections à coronavirus ()</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Récepteurs viraux ()</term>
<term>Récepteurs viraux (immunologie)</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Vaccins antiviraux ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Dipeptidyl Peptidase 4</term>
<term>Receptors, Virus</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Dipeptidyl Peptidase 4</term>
<term>Receptors, Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dipeptidyl Peptidase 4</term>
<term>Receptors, Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Coronavirus</term>
<term>Dipeptidyl peptidase 4</term>
<term>Infections à coronavirus</term>
<term>Récepteurs viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus</term>
<term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Coronavirus</term>
<term>Dipeptidyl peptidase 4</term>
<term>Récepteurs viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Design</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Antiviraux</term>
<term>Conception de médicament</term>
<term>Coronavirus</term>
<term>Dipeptidyl peptidase 4</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Récepteurs viraux</term>
<term>Vaccins antiviraux</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is becoming another "SARS-like" threat to the world. It has an extremely high death rate (∼50%) as there is no vaccine or efficient therapeutics. The identification of the structures of both the MERS-CoV receptor binding domain (RBD) and its complex with dipeptidyl peptidase 4 (DPP4), raises the hope of alleviating this currently severe situation. In this review, we examined the molecular basis of the RBD-receptor interaction to outline why/how could we use MERS-CoV RBD to develop vaccines and antiviral drugs.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24342026</PMID>
<DateCompleted><Year>2014</Year>
<Month>09</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0929-6646</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>113</Volume>
<Issue>3</Issue>
<PubDate><Year>2014</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the Formosan Medical Association = Taiwan yi zhi</Title>
<ISOAbbreviation>J. Formos. Med. Assoc.</ISOAbbreviation>
</Journal>
<ArticleTitle>The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development.</ArticleTitle>
<Pagination><MedlinePgn>143-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jfma.2013.11.006</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0929-6646(13)00402-6</ELocationID>
<Abstract><AbstractText>The newly emerged Middle East respiratory syndrome coronavirus (MERS-CoV) is becoming another "SARS-like" threat to the world. It has an extremely high death rate (∼50%) as there is no vaccine or efficient therapeutics. The identification of the structures of both the MERS-CoV receptor binding domain (RBD) and its complex with dipeptidyl peptidase 4 (DPP4), raises the hope of alleviating this currently severe situation. In this review, we examined the molecular basis of the RBD-receptor interaction to outline why/how could we use MERS-CoV RBD to develop vaccines and antiviral drugs.</AbstractText>
<CopyrightInformation>Copyright © 2013. Published by Elsevier B.V.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName>
<ForeName>Nan</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Yun</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Jin-Chun</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Feng</LastName>
<ForeName>Ling</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bao</LastName>
<ForeName>Jin-Ku</ForeName>
<Initials>JK</Initials>
<AffiliationInfo><Affiliation>School of Life Sciences & Key Laboratory of Bio-resources, Ministry of Education, Sichuan University, Chengdu 610064, China. Electronic address: baojinku@scu.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>12</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Singapore</Country>
<MedlineTA>J Formos Med Assoc</MedlineTA>
<NlmUniqueID>9214933</NlmUniqueID>
<ISSNLinking>0929-6646</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.14.5</RegistryNumber>
<NameOfSubstance UI="D018819">Dipeptidyl Peptidase 4</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018819" MajorTopicYN="N">Dipeptidyl Peptidase 4</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="Y">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Middle East</Keyword>
<Keyword MajorTopicYN="N">coronavirus</Keyword>
<Keyword MajorTopicYN="N">drug design</Keyword>
<Keyword MajorTopicYN="N">vaccines</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>09</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>10</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>11</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24342026</ArticleId>
<ArticleId IdType="pii">S0929-6646(13)00402-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.jfma.2013.11.006</ArticleId>
<ArticleId IdType="pmc">PMC7127315</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Scand J Immunol. 2001 Sep;54(3):249-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11555388</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Cell Biol. 2003 Feb;82(2):53-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12647932</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Res. 2013 Sep;23(9):1069-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23938293</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2012 Apr;86(7):3995-4008</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22278237</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19198616</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5063-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690074</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2013 Mar 14;495(7440):251-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23486063</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2013 Oct;87(19):10777-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23903833</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nucleic Acids Res. 2009 Jul;37(Web Server issue):W623-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19498078</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Thorac Dis. 2013 Aug;5 Suppl 2:S142-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23977435</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell Res. 2013 Aug;23(8):986-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23835475</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Protein Cell. 2012 Nov;3(11):803-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23143870</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Crit Rev Clin Lab Sci. 2003 Jun;40(3):209-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12892317</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21059682</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Struct Biol. 2003 Jan;10(1):19-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12483204</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 Jul;13(7):573-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23977673</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2013 Aug 8;500(7461):227-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23831647</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2005 Mar 30;334(1):74-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15749124</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2013 Jun 27;368(26):2487-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23718156</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Chem Inf Model. 2012 Jul 23;52(7):1757-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22587354</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2013 Sep;87(17):9939-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23824801</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microbes Infect. 2013 Jul-Aug;15(8-9):625-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23791956</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect. 2013 May;66(5):464-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23266463</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23727167</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chem Cent J. 2007 Mar 13;1:7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17880740</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2013 Aug;87(16):9379-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23785207</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2013 Aug 1;369(5):407-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23782161</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Exp Biol Med (Maywood). 2009 Oct;234(10):1117-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19546349</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virol J. 2013 Feb 28;10:66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23445530</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Formos Med Assoc. 2013 Jul;112(7):372-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23883791</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioinformatics. 2011 Dec 1;27(23):3315-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21994221</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B14 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001B14 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:24342026 |texte= The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24342026" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |